Northwestern Mutual Wealth Management’s MiNK Therapeutics INKT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio INKT Stock Details INKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210	Hold	18	–	–	﹤0.01%	3945
2026 Q1	$190	Hold	18	–	–	﹤0.01%	3945
2025 Q4	$201	Sell	18 -1	-5%	-$13	﹤0.01%	3803
2025 Q3	$266	Hold	19	–	–	﹤0.01%	3682
2025 Q2	$140	Buy	19 +1	+6%	+$8	﹤0.01%	3536
2025 Q1	$156	Sell	18 -1	-5%	-$9	﹤0.01%	3474
2024 Q4	$132	Hold	19	–	–	﹤0.01%	3471
2024 Q3	$143	Hold	19	–	–	﹤0.01%	3465
2024 Q2	$181	Hold	19	–	–	﹤0.01%	3364
2024 Q1	$168	Hold	19	–	–	﹤0.01%	3407
2023 Q4	$198	Hold	19	–	–	﹤0.01%	3349
2023 Q3	$204	Hold	19	–	–	﹤0.01%	3177
2023 Q2	$389	Buy	+19	New	+$381	﹤0.01%	3191

Other funds holding INKT

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Northwestern Mutual Wealth Management's INKT Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its MiNK Therapeutics (INKT) position steady in Q2 2026 at 18 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

Northwestern Mutual Wealth Management first reported a position in INKT in Q2 2023 and has held it in 13 quarters since. The position peaked at $389 in Q2 2023. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

Northwestern Mutual Wealth Management held 18 shares of MiNK Therapeutics worth $210 as of Q2 2026.
Northwestern Mutual Wealth Management left its MiNK Therapeutics share count unchanged in Q2 2026.
MiNK Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3945 holding.
Northwestern Mutual Wealth Management first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 13 quarters since.
Northwestern Mutual Wealth Management's MiNK Therapeutics position peaked at $389 in Q2 2023.
27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.